REVIEW
|
doi:10.20944/preprints202312.2256.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
acute myeloid leukemia; TP53 mutations; TP53-mutated acute myeloid leukemia; novel targeted AML therapies; AML immunotherapies
Online: 29 December 2023 (05:27:17 CET)